logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xin Du

Capital Medical University
H指数:39
被引数:5,919

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma

II期研究：zevorcabtagene autoleucel，一种靶向BCMA的全人源CAR T细胞疗法，在复发/难治性多发性骨髓瘤患者中的应用

Experimental Hematology & Oncology
IF13.5
2025-10-020
OAAI
Wenming Chen; Chengcheng Fu; Baijun Fang; Aibin Liang; Zhongjun Xia; Yanjuan He; Jin Lu; Hui Liu; Ming Hou; Zhen Cai; Wei Yang; Siguo Hao; Songfu Jiang; Hongmei Jing; Jing Liu; Xin Du; Rong Fu; Heng Mei; Zunmin Zhu; Yanli Yang; Hong Liu; Xingxing Meng; Nishanthan Rajakumaraswamy; Daijing Yuan; Huamao Wang; Zonghai Li
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey
ACTA HAEMATOLOGICA
IF1.1
2025-10-010
PRE
Zhuang, Junling; Shi, Hongxia; Liu, Xiaoli; Duan, Minghui; Du, Xin; Qin, Ling; Hui, Wuhan; Liang, Rong; Wang, Meifang; Chen, Ye; Li, Dongyun; Yang, Wei; Tang, Gusheng; Zhang, Weihua; Kuang, Xia; Su, Wei; Han, Yanqiu; Lan, Xialu; Chen, Limei; Xu, Jihong; Liu, Zhuogang; Huang, Jian; Zhao, Chunting; Tong, Hongyan; Hu, Jianda; Chen, Chunyan; Chen, Xiequn; Xiao, Zhijian; Jiang, Qian
Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China

流感疫苗接种以改善急性心力衰竭患者的结局（PANDA II）：一项在中国开展的多区域、季节性、医院为基础的集群随机对照试验

lancet
IF0
2025-08-300
PRE
Craig S Anderson; Chang Hua; Zhiyan Wang; Chi Wang; Chao Jiang; Rong Liu; Rong Han; Qiang Li; Sana Shan; Laurent Billot; C Raina Macintyre; Anushka Patel; Hongjia Zhang; Changsheng Ma; Jianzeng Dong; Xin Du
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study

维奈克拉联合阿扎胞苷，含或不含高三尖杉酯碱，随后进行异基因造血细胞移植，用于复发/难治性急性髓系白血病患者的多中心队列研究

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-05-210
PRE
Yiling Ye; Xinyu Liu; Huajuan Dai; Jing Hu; Guopan Yu; Yu Zhang; Guangyang Weng; Dongjun Lin; Xin Du; Jie Xiao; Zhiqiang Sun; Hongyu Zhang
Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF: The PROMPT-AF Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2025-02-041
PRE
Sang, Caihua; Liu, Qiang; Lai, Yiwei; Xia, Shijun; Jiang, Ruhong; Li, Songnan; Guo, Qi; Li, Qifan; Gao, Mingyang; Guo, Xueyuan; Huang, Lihong; Liu, Nian; Jiang, Chenxi; Zuo, Song; Liu, Xiaoxia; Li, Mengmeng; Ge, Weili; Song, Shangming; Chen, Lianghua; Xie, Shuanglun; Zou, Jiangang; Chen, Ke; Liu, Xiangfei; Hu, Hesheng; Wang, Xinhua; Zhang, Jinlin; Wang, Zhaojun; Wang, Chi; He, Liu; Jiang, Chao; Tang, Ribo; Zhou, Ning; Wang, Yunlong; Long, Deyong; Du, Xin; Jiang, Chenyang; Macle, Laurent; Dong, Jianzeng; Ma, Changsheng
Subgroup Analyses of Phase 2 Study: Evaluating the Efficacy of Fully Human BCMA-Targeting CAR T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

II期研究的亚组分析：评估全人源BCMA靶向CAR T细胞（Zevorcabtagene autoleucel）在复发/难治性多发性骨髓瘤患者中的疗效

BLOOD
IF23.1
2024-11-050
PRE
Chen, Wenming; Fu, Chengcheng; Fang, Baijun; Liang, Aibin; Xia, Zhongjun; He, Yanjuan; Lu, Jin; Liu, Hui; Hou, Ming; Cai, Zhen; Yang, Wei; Hao, Siguo; Jiang, Songfu; Jing, Hongmei; Liu, Jing; Du, Xin; Fu, Rong; Mei, Heng; Zhu, Zunmin; Yang, Yanli; Liu, Hong; Meng, Xingxing; Rajakumaraswamy, Nishanthan; Zheng, Wei; Wang, Huamao; Li, Zonghai
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide

贝兰他单抗马福替尼联合泊马利度胺和地塞米松与泊马利度胺联合硼替佐米和地塞米松治疗复发/难治性多发性骨髓瘤：在接受过包含来那度胺的1线先前治疗的患者亚组分析

BLOOD
IF23.1
2024-11-053
PRE
Beksac, Meral; Garcia, Esther Gonzalez; Delimpasi, Sosana; Robak, Pawel; Karunanithi, Kamaraj; De Arriba, Felipe; Radocha, Jakub; Kim, Kihyun; Voloshin, Sergey; Zherebtsova, Vera; Osipov, Iurii; Mateos, Maria-Victoria; Zafar, Syed F.; Pour, Ludek; Spicka, Ivan; Suzuki, Kazuhito; Du, Xin; Wilkes, Jodie; Maroj, Brijesh; Morris, Kristin; Ma, Jie; Polinkovsky, Margaret; Wang, Zhaohui; Zhou, Xiaoou L.; Fulci, Giulia; Sule, Neal; Kremer, Brandon; Opalinska, Joanna; Trudel, Suzanne; Dimopoulos, Meletios A.
Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

每周 Selinexor、Bortizomib 和 Dexamethasone (SVd) 与每周两次 Bortizomib 和 Dexamethasone (Vd) 在中国复发性和难治性多发性骨髓瘤 (RRMM) 患者中的比较：Bench 研究的初步分析

BLOOD
IF23.1
2024-11-050
PRE
Lu, Jin; Geng, Liangquan; Chen, Lijuan; Liu, Peng; Zhong, Yuping; Liu, Zhuogang; Xia, Zhongjun; Mi, Jianqing; Li, Chunrui; Zhang, Xi; He, Yanjuan; Wei, Yongqiang; Fang, Baijun; Li, Fei; Cai, Zhen; Wang, Yafei; Huang, Dongping; Liu, Hong; Hou, Ming; Fu, Rong; Du, Xin; Fang, Xiaosheng; Zeng, Qingshu; Gao, Wen; Wang, Wei; Chang, Chunkang; Ouyang, Guifang; Liu, Jing; Weng, Jianyu; Huang, Xiaobing; Yu, Yang; Guo, Zhi; Zhao, Jun; Hou, Jian
SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

SG301，一种新型抗CD38单克隆抗体，在复发/难治性多发性骨髓瘤患者中的研究：一项首次人体、多中心、I期临床试验

BLOOD
IF23.1
2024-11-050
PRE
Tian, Ying; Zhou, Keshu; Lin, Quande; Qian, Wenbin; Yang, Wei; Sao, Li; Yuan, Guolin; Yan, Xiaojing; Ma, Liangming; Zhou, Xin; Liu, Lihong; Zhu, Fangbing; Zuo, Xuelan; Du, Xin; Ji, Xu; Zhang, Xuzhao; Shen, Jing; Zhou, Hai; Li, Na; Chen, Wenming

研究方向

暂未获取到该数据
J
Jianyu Weng
H 指数:25论文数:174被引数:3,327
黄
黄晓君
H 指数:86论文数:2,129被引数:3.6万
D
Dongjun Lin
H 指数:22论文数:155被引数:1,595
S
Suning Chen
H 指数:29论文数:475被引数:3,940
张
张艳丽
H 指数:41论文数:463被引数:6,198
Q
Qifa Liu
H 指数:52论文数:735被引数:1.1万
Q
Qian Jiang
H 指数:43论文数:660被引数:8,235
N
Na Xu
H 指数:24论文数:265被引数:2,184
J
Jie Jin
H 指数:60论文数:1,289被引数:1.8万
Z
Zhen Cai
H 指数:48论文数:770被引数:9,668